$ARKR

$4.55 +$0.04 (0.89%) Close

$ARKR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ARKR Management Team

Ms. Jennifer Jordan

Co-Chief Operating Officer

Age 62

Compensation -

Sex Female

Mr. Samuel Weinstein

Co-Chief Operating Officer

Age 30

Compensation $172.5K USD

Sex Male

Mr. Michael Weinstein

Chairman of the Board

Chief Executive Officer

Age 81

Compensation $1.259M USD

Sex Male

Mr. Anthony Sirica

President

Chief Financial Officer

Director

Age 61

Compensation $737.7K USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Jennifer Jordan Co-Chief Operating Officer	62	-	Female
Mr. Samuel Weinstein Co-Chief Operating Officer	30	$172.5K USD	Male
Mr. Michael Weinstein Chairman of the Board Chief Executive Officer	81	$1.259M USD	Male
Mr. Anthony Sirica President Chief Financial Officer Director	61	$737.7K USD	Male

Board of Directors

From the proxy statement filed Jan 26, 2026

Directors

serving now

Independent

4 of 4

stated in the proxy; 2 not stated

Average tenure

20.8 years

from year joined

CEO also chairs the board

Yes

Michael Weinstein

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Michael Weinstein Board chair, CEO	82	1983 43 years	Not stated	None stated	None stated	Paid as CEO
Anthony J. Sirica Executive officer	62	2018 8 years	Not stated	None stated	None stated	Not stated
Marcia Allen	75	2003 23 years	Independent	Compensation Committee Audit Committee Nominating and Corporate Governance Committee	INmune Bio, Inc.	$47,500
Jessica Kates	47	2022 4 years	Independent	Audit Committee	None stated	$46,000
Bruce R. Lewin	78	2000 26 years	Independent	Audit Committee · Chair Nominating and Corporate Governance Committee	None stated	$61,000
Stephen Novick	85	2005 21 years	Independent	Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair	None stated	$41,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Jan 26, 2026

Mr. Pascal

resigned as a director and Chief Operating Officer of the Company, effective April 30, 2024

$500,000

three-year term

Three-year Pascal Advisory Agreement to provide general operational advice to the Company for an annual fee.

Open in proxy

Mr. Pascal

resigned as a director and Chief Operating Officer of the Company, effective April 30, 2024

Amount not stated

term of the Pascal Advisory Agreement

Company continues to provide health insurance to Mr. Pascal for the term of the advisory agreement.

Open in proxy

Comments

Company Executives

$ARKR Management Team

Ms. Jennifer Jordan

Mr. Samuel Weinstein

Mr. Michael Weinstein

Mr. Anthony Sirica

Board of Directors

Related-party transactions